Orchid Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2021, to consider and approve the Unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021. As required under the SEBI (Prohibition of insider Trading) Regulations, the trading window for dealing in securities of the Company has been closed with effect from October 01, 2021 till 48 hours of the declaration of the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2021 and the same is already been informed.
The above information is a part of company’s filings submitted to BSE.
